The Clinical Significance of IGF-I in Maternal Serum During Pregnancy in Type 1 Diabetes
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Insulin-like growth factors (IGFs) constitute a system of peptides that promote mitosis, growth, and organ development by both paracrine and endocrine pathways, their bioavailability being modulated by at least six specific IGF-binding proteins (IGFBP). In type 1 diabetic pregnancies IGF-I and -II in maternal serum are associated with birth weight and their action modulated by IGFBP-3 and phosphorylated isoforms of IGFBP-1. Pregnancy-associated plasma protein-A (PAPP-A), a proteolytic substance of IGFBPs, is probably a modulator in early diabetic pregnancy while human placental growth hormone (hPGH) regulates the effect of IGF-I in pregnancy of diabetic and non-diabetic pregnancies. IGF-I in maternal serum increases concomitantly with progression of diabetic retinopathy despite good glycemic control in pregnancy. The role of the new insulin analogues in improving this effect has yet to be established. Retinopathy in pregnancy is associated with an elevated level of fibroblast growth factor-2 (FGF-2) and highly-phosphorylated IGFBP-1, the latter further increasing the level of free IGF-I and FGF-2. Thus, the effect on development of retinopathy may be directly mediated by IGF-I or indirectly by a modifying effect of IGFBP-3 and phosphorylated isoforms of IGFBP-1 with FGF-2 as a mediator.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of the two available long-acting insulin analogs, detemir has a theoretical advantage over glargine during pregnancy because glargine's much higher affinity for the IGF-1 receptor (150) raises concerns about increased mitogenic activity (150–152).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [151]
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Lawrence, J. B., Oxvig, C., Overgaard, M. T., Sottrup-Jensen, L., Gleich, G. J., Hays, L. G., Yates, J. R., & Conover, C. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3149 · Cited by 706
SUIKKARI, A.-M., KOIVISTO, V. A., RUTANEN, E.-M., YKI-JÄRVINEN, H., KARONEN, S.-L., & SEPPÄLÄ, M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-266 · Cited by 483 · cited 1×
“On the fetal side of placenta, IGF-I and II are mainly regulated by the IGFBP-1, which is GH independent, binds IGF-I more reluctantly than IGFBP-3, and is influenced by insulin in diabetic and non-diabetic subjects [34].”
BackgroundThe Pregnant Diabetic and Her Newborn
Farquhar, J. W. (1977) · Archives of Disease in Childhood · doi:10.1136/adc.52.8.671 · Cited by 406
GIUDICE, L. C., FARRELL, E. M., PHAM, H., LAMSON, G., & ROSENFELD, R. G. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-806 · Cited by 361 · cited 3×
“Similar techniques were applied; however, the mixture of sampling time and unpaired measurements (89 women between week 6 and 42 [36], 15 women between gestational week 20 and 41 [37]) may have influenced the latter findings.”
BackgroundMethodHOSSENLOPP, P., SEGOVIA, B., LASSARRE, C., ROGHANI, M., BREDON, M., & BINOUX, M. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-797 · Cited by 340 · cited 2×
“Similar techniques were applied; however, the mixture of sampling time and unpaired measurements (89 women between week 6 and 42 [36], 15 women between gestational week 20 and 41 [37]) may have influenced the latter findings.”
BackgroundMethodInsulin-like Growth Factors: Studies in Diabetics with and without Retinopathy
Merimee, T. J., Zapf, J., & Froesch, E. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198309013090904 · Cited by 280 · cited 3×
“Mitosis and growth of the retina and vitreous is promoted by IGFs [39-41].”
Grant, M., Russell, B., Fitzgerald, C., & Merimee, T. J. (1986) · Diabetes · doi:10.2337/diab.35.4.416 · Cited by 268 · cited 3×
“Mitosis and growth of the retina and vitreous is promoted by IGFs [39-41].”
BackgroundResultMirlesse, V., Frankenne, F., Alsat, E., Poncelet, M., Hennen, G., & Evain-Brion, D. (1993) · Pediatric Research · doi:10.1203/00006450-199310000-00011 · Cited by 202 · cited 1×
“The birth weight appears to correlate well with hPGH and IGF-I and suggestive of hPGH regulation of IGF-I in diabetic as well as in non-diabetic pregnancy [23,30,32,33], consequently, a low level of hPGH is associated with low maternal IGF-I in pregnancies complicated by intrauterine growth restriction [23,30].”
BackgroundDIABETES, DIABETIC ANGIOPATHY, AND GROWTH HORMONE
Lundbæk, K., Jensen, V., STEEN OLSEN, T., Ørskov, H., JUEL CHRISTENSEN, N., Johansen, K., PRANGE HANSEN, Å., & Østerby, R. (1970) · The Lancet · doi:10.1016/s0140-6736(70)92706-6 · Cited by 201 · cited 1×
“Since it was shown that pituitary ablation could halt proliferative diabetic retinopathy accompanied by a manifold reduction of IGF-I, increased focus has been on the hormonal changes with growth stimulating potential, which accompanies pregnancy [38,39].”
BackgroundMcIntyre, H. D. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1143 · Cited by 175
Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies
Caufriez, A., Frankenne, F., Hennen, G., & Copinschi, G. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.4.e572 · Cited by 157 · cited 1×
“The birth weight appears to correlate well with hPGH and IGF-I and suggestive of hPGH regulation of IGF-I in diabetic as well as in non-diabetic pregnancy [23,30,32,33], consequently, a low level of hPGH is associated with low maternal IGF-I in pregnancies complicated by intrauterine growth restriction [23,30].”
BackgroundWestwood, M. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1735 · Cited by 156 · cited 1×
“Phosphorylation of IGFBP-1 is another way of regulating the bioavailability of IGF-I and –II [10,11].”
BackgroundBereket, A., Lang, C. H., Blethen, S. L., Gelato, M. C., Fan, J., Frost, R. A., & Wilson, T. A. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.4.7536205 · Cited by 137
Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes
Temple, R. C., Aldridge, V. A., Sampson, M. J., Greenwood, R. H., Heyburn, P. J., & Glenn, A. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00535.x · Cited by 131 · cited 2×
“Women with proliferative retinopathy have elevated HbA1c levels, which have been shown to be associated with higher IGF-I in nonpregnant, diabetic subjects [2,42,43].”
BackgroundGiudice, L. C., Martina, N., Crystal, R. A., Tazuke, S. I., & Druzin, M. L. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70598-2 · Cited by 126
Damm, P., & Mølsted‐Pedersen, L. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90656-x · Cited by 116
Reece, E. A., Wiznitzer, A., Le, E., Homko, C. J., Behrman, H. R., & Spencer, E. (1994) · PubMed · Cited by 105
Regulation of IGF bioavailability in pregnancy
Gibson, J. M., Aplin, J. D., White, A., & Westwood, M. (2001) · Molecular Human Reproduction · doi:10.1093/molehr/7.1.79 · Cited by 101 · cited 2×
“Phosphorylation seems to be the major mode of regulation of IGFBP-1 [35] as the phosphorylated isoforms act differently on the regulation of IGFs.”
BackgroundPfeiffer, A. F. H., Spranger, J., Meyer-Schwickerath, R., & Schatz, H. (1997) · Diabetes · doi:10.2337/diab.46.2.s26 · Cited by 95
Chantelau, E. (1998) · British Journal of Ophthalmology · doi:10.1136/bjo.82.7.725 · Cited by 85 · cited 1×
“The change over gestational week in levels of IGF-I may in part explain previous conflicting reports on correlation between retinopathy and IGF-I in diabetes mellitus [44-48].”
Kajantie, E. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2171 · Cited by 85
Holmes, R. P., Holly, J. M. P., & SOOTHILL, P. W. (1998) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10005.x · Cited by 68 · cited 2×
“The described dynamic changes in IGF-I with increasing gestational age [20,21] may explain previous conflicting reports on correlation of birth weight with maternal serum IGF-I in non-diabetic and diabetic pregnancies [3,6,15,16,22-26].”
BackgroundResultFuglsang, J., Lauszus, F., Flyvbjerg, A., & Ovesen, P. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030726 · Cited by 61 · cited 3×
“The endogenous GH is replaced during pregnancy by hPGH, which is supposed to exert similar effects [23,26].”
BackgroundResultSelf-citationSimmons, D. S. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608282 · Cited by 56
Increased Serum IGF-I During Pregnancy Is Associated With Progression of Diabetic Retinopathy
Lauszus, F. F., Klebe, J. G., Bek, T., & Flyvbjerg, A. (2003) · Diabetes · doi:10.2337/diabetes.52.3.852 · Cited by 55 · cited 4×
“However, we failed to confirm such an association with IGF-I [21].”
BackgroundResultSelf-citationGibson, M., Westwood, M., Lauszus, F. F., Klebe, J. G., Flyvbjerg, A., & White, A. E. (1999) · Diabetes · doi:10.2337/diabetes.48.2.321 · Cited by 52 · cited 6×
“Phosphorylation of IGFBP-1 is another way of regulating the bioavailability of IGF-I and –II [10,11].”
BackgroundSelf-citationĐelmiš, J., Dražančić, A., Ivanišević, M., & Suchanek, E. (1992) · Journal of Perinatal Medicine · doi:10.1515/jpme.1992.20.1.47 · Cited by 47
Pedersen, J. F., Sørensen, S., & Ruge, S. (1995) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349509024379 · Cited by 47
Wang, H., Lee, J., & Soong, Y. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57598-0 · Cited by 44
LAUSZUS, F. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01189-9 · Cited by 41
Self-citationFrystyk, J., Bek, T., Flyvbjerg, A., Skjærbæk, C. B., & Ørskov, H. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00921.x · Cited by 37 · cited 1×
“In one study low free IGF-I level was reported in type 1 diabetic patients with retinopathy compared with patients without diabetic retinopathy, whereas other studies showed the opposite [39-41,46,47,50].”
ResultInsulin-like growth factor 1 and its binding protein 1 during normal and diabetic pregnancies.
Whittaker, P. G., Stewart, M., Taylor, A., Howell, R. J. S., & Lind, T. (1990) · PubMed · Cited by 36
Caufriez, A., Frankenne, F., Hennen, G. P., & Copinschi, G. (2008) · Hormone Research · doi:10.1159/000184147 · Cited by 35
Hyer, S. L., Sharp, P., Sleightholm, M. A., Burrin, J. M., & KOHNER, E. M. (1989) · Hormone and Metabolic Research · doi:10.1055/s-2007-1009140 · Cited by 33
Pedersen, J. F., Søorensen, S., & Mølsted‐Pedersen, L. (1998) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.1998.770204.x · Cited by 29 · cited 2×
“IGFBPs, is found with lower levels in diabetic women than in a control group in the first 12-14 weeks indicating that proteolysis is less pronounced [13].”
BackgroundIncreased Levels of Serum Fibroblast Growth Factor-2 in Diabetic Pregnant Women with Retinopathy1
Hill, D. J., Flyvbjerg, A., Arany, E. J., Lauszus, F. F., & Klebe, J. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3915 · Cited by 29
Self-citationInsulin-Like Growth Factors in Fetal Macrosomia with and without Maternal Diabetes
Hill, W. C., Pelle-Day, G., Kitzmiller, J. L., & Spencer, M. (2008) · Hormone Research · doi:10.1159/000181285 · Cited by 23
SELF‐MONITORING OF BLOOD GLUCOSE IN PREGNANT DIABETICS
Espersen, T., & Klebe, J. G. (1985) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348509154680 · Cited by 15 · cited 1×
“This observation suggests that factors other than glycemic regulation to be responsible for macrosomia despite reports of improved glycemic control during pregnancy and less adverse perinatal outcome in the last decade [18,19].”
BackgroundFeto-maternal interaction of IGF-I and its binding proteins in fetal growth
Iwashita, M., Kobayashi, M., Matsuo, A., Nakayama, S., Mimuro, T., Takeda, Y., & Sakamoto, S. (1992) · Early Human Development · doi:10.1016/0378-3782(92)90148-a · Cited by 14 · cited 1×
“The described dynamic changes in IGF-I with increasing gestational age [20,21] may explain previous conflicting reports on correlation of birth weight with maternal serum IGF-I in non-diabetic and diabetic pregnancies [3,6,15,16,22-26].”
ResultIGF-1 levels in diabetic pregnant women and their infants.
Biase, N. D., Napoli, A., Caiola, S., Buongiorno, A. M., Maroccia, E., Sabbatini, A., & Fallucca, F. (1997) · PubMed · Cited by 9
Pedersen, J. F., Juul, A., Mølsted‐Pedersen, L., & Skakkebek, N. E. (1995) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1995.tb10884.x · Cited by 5 · cited 2×
“However, due to wide variations in sampling time, the influence of time remained unresolved with no definitive association with macrosomia or fetal growth restriction [6,22,23] and in some studies on diabetes mellitus [14,25,27,28].”
Background
Cited by
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Pregnancy-associated Retinal Diseases and Their Management
Errera, M., Kohly, R. P., & da Cruz, L. (2013) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.08.001 · Cited by 147
Grissa, O., Yessoufou, A., Mrisak, I., Hichami, A., Amoussou-Guénou, D., Grissa, A., Djrolo, F., Moutairou, K. A., Miled, A., Khaïri, H., et al. (2010) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-10-7 · Cited by 84
Hami, J., Shojae, F., Vafaee-Nezhad, S., Lotfi, N., Kheradmand, H., & Haghir, H. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.412 · Cited by 56
Mathiesen, E. R., Damm, P., Jovanovic, L., McCance, D. R., Thyregod, C., Jensen, A. B., & Hod, M. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1213 · Cited by 43
“pregnancies [47], although a small decrease in IGF-1”
Background
Metadata
- Authors
- Lauszus, F. F.
- Affiliations
- Regionshospitalet Herning (DK)
- Corresponding author
- Finn Friis Lauszus
- ORCID
- Finn Friis Lauszus
- Venue
- Current Diabetes Reviews
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2007-08-01
- Volume
- 3
- Issue
- 3
- Pages
- 194-197
- ISSN
- 1573-3998 (ISSN-L)
- OpenAlex
- W2116566960
- Cited by
- 19
- References
- 42
- Citations by year
- 2024: 1 · 2021: 1 · 2019: 1 · 2016: 2 · 2015: 1 · 2013: 2 · 2012: 4
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Diabetes Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- insulin-like growth factor I, type 1 diabetes, diabetes in pregnancy, maternal serum, IGF binding proteins, IGFBP-3, PAPP-A, placental growth hormone, diabetic retinopathy, fibroblast growth factor 2, birth weight, insulin analogues
- MeSH terms
- Birth Weight, Diabetic Retinopathy, Female, Humans, Infant, Newborn, Insulin-Like Growth Factor I, Mothers, Pregnancy, Pregnancy in Diabetics, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.